Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $53,508 | 10 | 92.1% |
| Food and Beverage | $4,054 | 122 | 7.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $490.00 | 2 | 0.8% |
| Gift | $38.80 | 2 | 0.1% |
| Travel and Lodging | $18.00 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $41,756 | 15 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $11,988 | 5 | $0 (2017) |
| Alcon Vision LLC | $893.08 | 8 | $0 (2024) |
| Allergan, Inc. | $839.83 | 23 | $0 (2022) |
| Alcon Laboratories Inc | $380.91 | 7 | $0 (2018) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $297.96 | 13 | $0 (2021) |
| ABBVIE INC. | $258.87 | 7 | $0 (2024) |
| Shire North American Group Inc | $254.96 | 6 | $0 (2019) |
| Kala Pharmaceuticals, Inc. | $245.19 | 10 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $212.33 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $484.80 | 14 | Alcon Vision LLC ($130.24) |
| 2023 | $988.09 | 14 | Alcon Vision LLC ($603.28) |
| 2022 | $410.88 | 16 | ABBVIE INC. ($116.98) |
| 2021 | $669.17 | 20 | Allergan, Inc. ($385.76) |
| 2020 | $41,930 | 21 | Sun Pharmaceutical Industries Inc. ($41,581) |
| 2019 | $440.67 | 15 | Bausch & Lomb, a division of Bausch Health US, LLC ($213.82) |
| 2018 | $731.37 | 19 | Allergan Inc. ($218.42) |
| 2017 | $12,454 | 18 | Valeant Pharmaceuticals North America LLC ($11,988) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR HANDPIECE, RXSIGHT INJECTOR CARTRIDGE | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/23/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: EYE CARE | ||||||
| 11/06/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $36.14 | General |
| Category: Ophthalmology | ||||||
| 09/03/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $41.95 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/13/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $130.24 | General |
| Category: Ophthalmology | ||||||
| 07/08/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| 06/20/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Ophthalmology | ||||||
| 05/24/2024 | Sight Sciences, Inc. | TEARCARE SYSTEM (Device) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Ophthalmology | ||||||
| 05/03/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $38.72 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/04/2024 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: Optics | ||||||
| 01/05/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: SOLUTION/ DROPS | ||||||
| 01/02/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Ophthalmology | ||||||
| 12/06/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: Ophthalmology | ||||||
| 11/13/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: TEPEZZA | ||||||
| 10/26/2023 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $99.86 | General |
| Category: EYE CARE | ||||||
| 08/23/2023 | Bausch & Lomb Americas Inc. | IC-8 Apthera IOL (Device) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Ophthalmology | ||||||
| 08/09/2023 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/21/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Ophthalmology | ||||||
| 06/29/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $162.18 | General |
| Category: Ophthalmology | ||||||
| 06/26/2023 | NEW WORLD MEDICAL,INC. | — | Food and Beverage | In-kind items and services | $79.94 | General |
| 06/23/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $34.40 | General |
| Category: Ophthalmology | ||||||
| 05/31/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Ophthalmology | ||||||
| 04/01/2023 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $310.15 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3, Multicenter, Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical Efficacy and Safety of ISV-305 (0.1% Dexamethasone) Compared to Vehicle in the Treatment of Subjects With Blepharitis | Sun Pharmaceutical Industries Inc. | $41,564 | 7 |
| A Phase 3, Multi-Center, Double-Masked, Vehicle-Controlled, Randomized, Parallel-Group Study to Assess Loteprednol Etabonate Ophthalmic Gel, 0.38 BID and TID versus Vehicle Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery | Valeant Pharmaceuticals North America LLC | $11,944 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,493 | 4,430 | $1.8M | $357,721 |
| 2022 | 21 | 3,285 | 4,163 | $1.7M | $344,897 |
| 2021 | 23 | 3,239 | 4,006 | $1.6M | $337,493 |
| 2020 | 23 | 2,855 | 3,434 | $1.2M | $279,773 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 911 | 1,232 | $450,912 | $125,656 | 27.9% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 92 | 131 | $550,855 | $61,482 | 11.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 380 | 636 | $161,544 | $47,669 | 29.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 264 | 264 | $115,896 | $30,134 | 26.0% |
| 92250 | Photography of the retina | Office | 2023 | 540 | 632 | $125,768 | $19,358 | 15.4% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 16 | 18 | $88,452 | $11,549 | 13.1% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 29 | 36 | $36,223 | $10,724 | 29.6% |
| 92134 | Imaging of retina | Office | 2023 | 211 | 225 | $27,450 | $7,620 | 27.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 131 | 180 | $48,780 | $7,161 | 14.7% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 32 | 40 | $37,378 | $7,109 | 19.0% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 293 | 341 | $24,893 | $6,786 | 27.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 104 | 104 | $20,072 | $5,665 | 28.2% |
| 92025 | Ct scan of cornea | Office | 2023 | 139 | 191 | $21,392 | $5,431 | 25.4% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 54 | 68 | $13,124 | $3,652 | 27.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 60 | 61 | $6,771 | $1,861 | 27.5% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 75 | 80 | $6,320 | $1,800 | 28.5% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 12 | 12 | $6,443 | $1,720 | 26.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 91 | 105 | $4,935 | $1,366 | 27.7% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 21 | 36 | $7,800 | $643.84 | 8.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 38 | 38 | $1,710 | $335.70 | 19.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 819 | 1,132 | $414,240 | $114,150 | 27.6% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 94 | 127 | $534,035 | $59,982 | 11.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 346 | 627 | $159,258 | $46,708 | 29.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 264 | 264 | $115,896 | $29,226 | 25.2% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 30 | 35 | $171,990 | $22,652 | 13.2% |
About Dr. Jonathan Macy, MD
Dr. Jonathan Macy, MD is a Ophthalmology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922020205.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Macy, MD has received a total of $58,109 in payments from pharmaceutical and medical device companies, with $484.80 received in 2024. These payments were reported across 137 transactions from 23 companies. The most common payment nature is "" ($53,508).
As a Medicare-enrolled provider, Macy has provided services to 12,872 Medicare beneficiaries, totaling 16,033 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Los Angeles, CA
- Active Since 07/24/2006
- Last Updated 02/14/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1922020205
Products in Payments
- LOTEMAX GEL (Drug) $11,944
- XIIDRA (Drug) $289.73
- LUMIGAN (Drug) $266.09
- INVELTYS (Drug) $245.19
- Constellation (Device) $241.93
- Clareon (Device) $162.18
- PROLENSA (Drug) $160.12
- RESTASIS (Drug) $158.10
- STELLARIS PC (Device) $149.47
- HYDRUS Microstent (Device) $130.95
- DURYSTA (Drug) $124.84
- ORA (Device) $120.03
- Tecnis 1-piece IOL (Device) $116.19
- OXERVATE (Drug) $114.51
- XDEMVY (Drug) $113.72
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $99.86
- Cequa (Drug) $87.32
- RESTASIS MULTIDOSE (Drug) $67.80
- TEPEZZA (Drug) $58.67
- RXSIGHT CONTACT LENS (Device) $51.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Los Angeles
Dr. Andrew Moshfeghi, Md, MD
Ophthalmology — Payments: $898,549
Dr. Barry Seibel, M.d, M.D
Ophthalmology — Payments: $893,403
Neda Shamie, M.d, M.D
Ophthalmology — Payments: $693,812
David Boyer, Md, MD
Ophthalmology — Payments: $514,544
David Hamilton, Od, OD
Ophthalmology — Payments: $477,856
Dr. Nicole Fram, Md, MD
Ophthalmology — Payments: $382,620